Tissue-factor/factor VIIa inhibition with higher-dose rNAPc2 reduces ischemia in patients with NSTE-ACS managed with an early invasive strategy in ANTHEM-TIMI 32

Author Department

Medicine

Document Type

Presentations, Research

Publication Date

9-1-2006

Share

COinS